| ExSt.2023.1545 |
Final Evaluation Governance and Decentralisation Program - GDP - in Mongolia |
DDC |
Terminé |
22.08.2022 |
22.08.2022 |
| 0142005547 |
Corona Immunitas Forschungsprogramm der SSPH+ zur Ausbreitung und den Auswirkungen der Coronapandemie in der Schweiz |
OFSP |
En cours |
25.08.2022 |
30.08.2023 |
| UTF 704.24.22 |
|
OFEV |
En cours |
29.08.2022 |
30.10.2023 |
| 0142005425 |
Grundlagen für den Postulatsbericht Fehlmann Rielle 19.3910 «Gesundheit der Frauen. Bessere Berücksichtigung ihrer Eigenheiten» |
OFSP |
En cours |
30.08.2022 |
29.06.2023 |
| ExSt.2023.1537 |
Mid-Term Review of Livestock Microinsurance component of Bangladesh Microinsurance Market Development Programme (BMMDP) Phase-1 |
DDC |
Terminé |
30.08.2022 |
30.08.2022 |
| 58741.1 IP-ENG |
Snow Imager: A new contactless device for optically measuring snow properties |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 58701.1 IP-ENG |
Manufacturing process optimization for high recycled content automotive aluminum sheet |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2026 |
| 0142005530 |
HTA CAR-T Zelltherapien tisagenlecleucel (Kymriah®) and axicabtagene ciloleucel (Yescarta®) |
OFSP |
En cours |
31.08.2022 |
30.05.2024 |
| 61835.1 IP-LS |
A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 61685.1 IP-LS |
ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101.951 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
29.02.2024 |
| 61188.1 IP-ICT |
Music DNA - Personalised Event Matching (Innolink: 101.564 IP-ICT) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 61831.1 IP-LS |
#One-Tube" Luminescent Reporter Phage Testing Platform for On-Site, Lab-Free Environmental Monitoring of Listeria spp. (Innolink: 100.728 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 22.05 |
Pre-emptive risk-benefit assessment for biocontrol agents of high-risk pests in Switzerland |
OFAG |
En cours |
31.08.2022 |
30.08.2023 |
| 61071.1 IP-LS |
PERFORM # Biomimetic 3D tumor microenvironment on-chip for preclinical testing of cancer immunotherapies (Innolink: 100.850 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
30.06.2024 |
| 61566.1 IP-SBM |
Agile and sustainable closed-loop supply chains in hydrogen powered mobility ecosystems (Innolink: 101.551 IP-SBM) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 61134.1 IP-SBM |
TIMEOUT: Beitrag von Zwischennutzungen zur nachhaltigen Umsetzung urbaner Transformationen (Innolink: 101.271 IP-SBM) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2025 |
| ExSt.2023.1502 |
Somalia Information and Resilience Building Action Programme (SIRA) - Phase 1 |
DDC |
Terminé |
31.08.2022 |
31.08.2022 |
| 62241.1 IP-LS |
Automated Human Milk Enricher for Nutrition Optimization for Low Weight Preterm Infants (Innolink: 100.060 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2023 |
| 62422.1 IP-LS |
Adenosine 2A receptor reactivation by positive allosteric modulators as a new therapeutic venue for unmet medical need in chronic inflammation (Innolink: 102.479 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
29.02.2024 |
| 61804.1 IP-EE |
SElf-Healing Lithium Metal Anode batteries (SELMA) (Innolink: 102.006 IP-EE) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 62957.1 IP-SBM |
Augmented Planning: Enabling broader participation (Innolink: 101.303 IP-SBM) |
INNOSUISSE |
En cours |
31.08.2022 |
30.04.2025 |
| 62913.1 IP-SBM |
Posmo Ethical Data Market - Creating a trustworthy data space for mobility (Innolink: 101.272 IP-SBM) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 62917.1 IP-SBM |
Version 2. Das "Diversity Office" als Teambooster (Innolink: 101.957 IP-SBM) |
INNOSUISSE |
En cours |
31.08.2022 |
31.08.2024 |
| 60471.1 IP-LS |
InSight - An automatable, holistic imaging technique to detect metastases in lymph node tissue (Innolink: 100.020 IP-LS) |
INNOSUISSE |
En cours |
31.08.2022 |
29.02.2024 |
| CTR00917 |
Metabolomic signature of patients undergoing radiotherapy: Can we quantify radiation exposure? |
IFSN |
En cours |
31.08.2022 |
29.06.2026 |